• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.01%

    Kythera Biopharmaceuticals, Inc. (KYTH)

    -NasdaqGS
    74.52 Up 0.04(0.05%) Jul 31, 4:00PM EDT
    |After Hours : 74.00 Down 0.52 (0.70%) Jul 31, 7:31PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue -   -   19,687  
    Cost of Revenue -   -  1,936  
    Gross Profit -   -   17,751  
    Operating Expenses
    Research Development47,840  33,974  43,184  
    Selling General and Administrative31,055  16,092  10,505  
    Non Recurring52,757   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (131,652) (50,066) (35,938)
    Income from Continuing Operations
    Total Other Income/Expenses Net188  135  (420)
    Earnings Before Interest And Taxes(131,464)(49,931)(36,358)
    Interest Expense4,157  1,980  441  
    Income Before Tax(135,621)(51,911)(36,799)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(135,621)(51,911)(36,799)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (135,621) (51,911) (36,799)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (135,621) (51,911) (36,799)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.